NFKB1 and Alzheimer disease: Indeed, recent studies have shown that the upregulation of miR-155 in patients with AD is reduced by using substances with anti-inflammatory properties or anti-NF-κB agents, such as curcumin or caffeic acid phenethyl ester [139].